HeartSciences (HSCS) Accumulated Expenses (2022 - 2026)

HeartSciences has reported Accumulated Expenses for 5 years, with the latest figure at $200483.0 in Q1 2026.

• For the quarter ending Q1 2026, Accumulated Expenses fell 36.53% year-over-year to $200483.0; the trailing twelve-month figure through Jan 2026 stood at $200483.0 (down 36.53% YoY), and the FY2025 full-year result was $177628.0, down 55.41% from the prior year.
• Accumulated Expenses for Q1 2026 stood at $200483.0, up from $160261.0 in the prior quarter.
• The five-year high for Accumulated Expenses was $1.1 million in Q2 2022, with the low at $5096.0 in Q4 2024.
• Historically, Accumulated Expenses has averaged $478528.4 across 5 years, with a median of $451939.0 in 2022.
• Annual changes were most pronounced in 2024 — Accumulated Expenses tumbled 99.34% — and 2025, when it soared 3044.84%.
• HeartSciences' Accumulated Expenses stood at $890654.0 in 2022, then retreated by 13.25% to $772670.0 in 2023, then plunged by 99.34% to $5096.0 in 2024, then soared by 3044.84% to $160261.0 in 2025, then rose by 25.1% to $200483.0 in 2026.
• The last three Accumulated Expenses figures came in at $200483.0 (Q1 2026), $160261.0 (Q4 2025), and $599287.0 (Q3 2025), per Business Quant data.